November 2009
New Crown Compounds Containing a 1,3,4-Thiadiazole Moiety:
Synthesis and Crystal Structure
1123
Table 4
Anisotropic displacement parameters for compound 2.
U11
U22
U33
U12
U13
U23
S1
N1
0.0197(1)
0.0307(4)
0.0299(4)
0.0202(3)
0.0184(3)
0.0219(3)
0.0285(4)
0.0351(5)
0.0395(5)
0.0310(4)
0.0212(3)
0.0308(4)
0.0710(9)
0.0705(9)
0.0190(3)
0.0185(3)
0.0238(4)
0.0276(4)
0.0303(5)
0.0271(4)
0.0281(4)
0.0274(4)
0.0462(6)
0.0249(3)
0.0329(3)
0.0198(1)
0.0340(4)
0.0368(4)
0.0239(4)
0.0274(4)
0.0228(4)
0.0278(4)
0.0262(5)
0.0268(5)
0.0278(5)
0.0213(4)
0.0388(5)
0.0432(7)
0.0474(7)
0.0282(4)
0.0231(4)
0.0246(4)
0.0353(6)
0.0528(7)
0.0447(6)
0.0253(4)
0.0366(5)
0.0464(7)
0.0239(3)
0.0274(3)
0.0184(1)
0.0237(3)
0.0219(3)
0.0209(3)
0.0209(3)
0.0269(4)
0.0367(5)
0.0514(7)
0.0525(7)
0.0366(5)
0.0267(4)
0.0209(4)
0.0249(5)
0.0277(5)
0.0279(4)
0.0388(5)
0.0587(7)
0.0604(8)
0.0419(6)
0.0284(4)
0.0450(6)
0.0426(6)
0.0432(7)
0.0358(4)
0.0215(3)
0.0020(1)
ꢂ0.0045(3)
ꢂ0.0052(3)
0.0018(3)
0.0016(1)
ꢂ0.0028(3)
ꢂ0.0018(3)
0.0021(3)
0.0029(3)
0.0053(3)
0.0080(4)
0.0117(5)
0.0095(5)
0.0039(4)
0.0037(3)
0.0014(3)
ꢂ0.0069(5)
0.0047(5)
0.0055(3)
0.0055(3)
0.0090(4)
0.0138(5)
0.0105(4)
0.0069(3)
0.0058(4)
0.0014(4)
0.0047(5)
ꢂ0.0003(3)
ꢂ0.0016(2)
0.0013(1)
0.0078(3)
0.0034(3)
N2
C1
0.0044(3)
C2
C3
C4
C5
C6
C7
C8
C9
0.0009(3)
0.0007(3)
ꢂ0.0016(3)
ꢂ0.0016(3)
ꢂ0.0081(4)
ꢂ0.0050(4)
0.0090(5)
ꢂ0.0042(3)
ꢂ0.0074(4)
ꢂ0.0048(4)
ꢂ0.0011(4)
0.0015(3)
0.0096(4)
0.0030(3)
ꢂ0.0037(4)
ꢂ0.0145(6)
0.0009(7)
ꢂ0.0036(4)
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
C20
O1
0.0030(5)
0.0061(5)
0.0005(3)
0.0017(3)
ꢂ0.0078(3)
ꢂ0.0049(4)
ꢂ0.0083(4)
ꢂ0.0237(5)
ꢂ0.0272(5)
ꢂ0.0135(4)
0.0119(4)
ꢂ0.0008(3)
ꢂ0.0052(4)
ꢂ0.0086(5)
ꢂ0.0033(4)
0.0003(3)
ꢂ0.0006(4)
ꢂ0.0087(5)
ꢂ0.0026(2)
ꢂ0.0054(3)
0.0177(5)
0.0154(5)
0.0062(3)
ꢂ0.0001(2)
O2
J ¼ 7.8 Hz, 2H); 6.94 (t, J ¼ 7.8 Hz, 2H), 6.07 (m, 2H); 5.17
(d, Jtrans ¼ 17 Hz, 2H), 5.12 (d, Jcis ¼ 9.8 Hz, 2H); 3.54 (d,
J ¼ 6.8 Hz, 4H); 13C NMR (CDCl3) d (ppm) C1 165.90; C2
120.92; C3 153.52; C4 127.20; C5 133.28; C6 116.60; C7
128.84; C8 34.05; C9 136.72; C10 116.60. MALDI-TOFMS:
m/z 351 (M þ 1). Anal. Calcd. for C20H18N2O2S: C, 68.55; H,
5.18; N, 7.99; S, 9.15. Found: C, 68.33; H, 5.14; N, 8.02; S,
9.14.
Synthesis of 2,5-Bis[2-hydroxy-3-trans-1-propenyl)phenyl]-
1,3,4-thiadiazole (4). A suspension of potassium tert-butoxide
(8.40 g, 75 mmol) in acetonitrile (40 mL) was heated at 120ꢀC
under stirring until it was completely dissolved. 2,5-Bis[3-
allyl-2-hydroxy)phenyl]-1,3,4-thiadiazole 3 (7.5 mmol) was
added and stirring was continued for 10 min. The solvent was
evaporated. The residue was treated and recrystallized from
ethanol: mp 172ꢀC; yield 61%; 1H NMR (CDCl3) d (ppm)
11.36 (s, 2H, OH); 7.87 (d, J ¼ 7.6 Hz, 2H), 7.52 (d, J ¼ 7.6
Hz, 2H); 6.95 (t, J ¼ 7.6 Hz, 2H), 6.82 (d, J ¼ 16 Hz, 2H),
6.35 (m, 2H); 1.81 (d, J ¼ 6.8 Hz, 6H); 13C NMR (CDCl3) d
(ppm) C1 169.98; C2 118.42; C3 157.35; C4 130.27; C5
135.53; C6 121.20; C7 133.92; C8 132.15; C9 125.79; C10
18.95. MALDI-TOFMS: m/z 351 (M þ 1). Anal. Calcd. for
C20H18N2O2S: C, 68.55; H, 5.18; N, 7.99; S, 9.15. Found: C,
68.30; H, 5.27; N, 7.83; S, 9.11.
The solvent was evaporated in vacuo and the solid residue was
heated under reflux with 200 mL of a potassium hydroxide so-
lution for 1 h. After cooling, the crude product was filtered,
washed with water, and recrystallized from ethanol.
Macrocycle 5. mp 85ꢀC; yield 31%; 8.28 (d, J ¼ 7.8 Hz,
2H), 7.42 (t, J ¼ 7.8 Hz, 2H), 7.32 (d, J ¼ 7.8 Hz, 2H), 6.04
(m, 2H), 5.14 (t, J ¼ 17 Hz, 4H); 4.02 (m, 4H), 3.88 (m, 4H),
3.52 (s, 4H); 3.33 (d, J ¼ 6.0 Hz, 4H). 13C NMR (CDCl3) d
(ppm) C1 163.72; C2 116.24; C3 154.43; C4 73.98; C5 69.77;
C6 71.48; C12 130.74; C13 126.12; C14 131.18; C15 125.93;
C16 34.23; C17 135.42.51; C18 117.79. MALDI-TOFMS: m/z
465 (M þ 1). Anal. Calcd. for C26H28N2O4S: C, 67.24; H,
6.07; N, 6.03; S, 6.90. Found: C, 67.11; H, 6.08; N, 5.94; S,
6.88.
Macrocycle 6. mp 128ꢀC; yield 27%; 8.44 (d, J ¼ 7.8 Hz,
2H), 7.85 (t, J ¼ 7.8 Hz, 2H), 7.28 (d, J ¼ 7.8 Hz, 2H), 6.85
(d, J ¼ 16 Hz, 2H), 6.04 (m, 2H); 4.10 (m, 4H), 3.93 (m, 4H),
3.56 (s, 4H); 1.78 (d, J ¼ 6.8 Hz, 6H). 13C NMR (CDCl3) d
(ppm) C1 167.41; C2 117.27; C3 156.43; C4 74.84; C5 69.30;
C6 71.33; C12 133.81; C13 125.35; C14 134.18; C15 126.63;
C16 137.11; C17 124.51; C18 18.83. MALDI-TOFMS: m/z
465 (M þ 1). Anal. Calcd. for C26H28N2O4S: C, 67.24; H,
6.07; N, 6.03; S, 6.90. Found: C, 67.09; H, 6.03; N, 5.98; S,
6.82.
General procedure for the synthesis of macrocycles (5)
and (6). A mixture of 2,5-bis[3-allyl-2-hydroxy)phenyl]-1,3,4-
thiadiazole 3 or 3,5-bis[2-hydroxy-3-trans-1-propenyl)phenyl]-
1,3,4-thiadiazole 4 (5 mmol), anhydrous potassium carbonate
(24 mmol), and ethylene or polyethylene glycol ditosylate
(5 mmol) in 150 mL of nonprotic polar solvent (acetone, ace-
tonitrile, etc.) was irradiated in multimode microwave for 9 h.
Synthesis of macrocycle (7). A suspension of macrocyclic
compound 6 (1 g, 2.15 mmol) in boiling water (100 mL) was
prepared, to which sodium carbonate crystals (0.5 g) were
added, and 4 g of finely powdered potassium permanganate
(4 g) was slowly introduced. The mixture was heated under
reflux until the purple color of the permanganate disappeared
(1–4 h). After cooling, the mixture was filtered to remove any
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet